Insider · CIK 0001791187
Daniel Lochner
Files at TECX (Tectonic Therapeutic, Inc.). First filing Feb 11, 2026, latest Feb 11, 2026.
In brief
Daniel Lochner files SEC Form 4 as CFO at TECX (Tectonic Therapeutic, Inc.). Since Feb 11, 2026, Daniel Lochner has reported 1 open-market buy worth $130k and 0 open-market sells worth $0, the latest filed on Feb 11, 2026.
A track record needs three past buys with six months of prices behind them; Daniel Lochner has 0, so none is measured yet.
The newest scored trade: bought $130k of TECX on Feb 10, 2026, filed Feb 11, 2026, scored 55 (moderate). In the last 12 months: 1 buy worth $130k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TECX: Tectonic Therapeutic, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 55Moderate | Tectonic Therapeutic, Inc. | $130k 6,000 shares | +23% | +43% from low-41% from high |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | TECX Tectonic Therapeutic, Inc. | FTax withholding Common Stock | -520 | $23.67 | $12k | 58,024 | 11 d ago |
| Sep 3, 2026 | TECX Tectonic Therapeutic, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +24,250 | $0.00 | $0 | 24,250 | 35 d ago |
| Jun 11, 2026 | TECX Tectonic Therapeutic, Inc. | AGrant or award Performance Stock Option (Right to Buy)derivative | +7,500 | $0.00 | $0 | 7,500 | Jun 12, 2026 |
| Mar 4, 2026 | TECX Tectonic Therapeutic, Inc. | AGrant or award Common Stock | +26,500 | $0.00 | $0 | 58,544 | Mar 5, 2026 |
| Mar 4, 2026 | TECX Tectonic Therapeutic, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +24,250 | $0.00 | $0 | 24,250 | Mar 5, 2026 |
| Feb 10, 2026 | TECX Tectonic Therapeutic, Inc. | POpen-market purchase Common Stock | +6,000 | $21.61 | $130k | 32,044 | Feb 11, 2026 |
| Feb 4, 2026 | TECX Tectonic Therapeutic, Inc. | FTax withholding Common Stock | -2,077 | $23.22 | $48k | 26,044 | Feb 10, 2026 |
| Sep 25, 2025 | TECX Tectonic Therapeutic, Inc. | AGrant or award Common Stock | +5,430 | $0.00 | $0 | 28,121 | Sep 29, 2025 |
| Sep 25, 2025 | TECX Tectonic Therapeutic, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +9,860 | $0.00 | $0 | 9,860 | Sep 29, 2025 |
Questions about Daniel Lochner
Answered from the filings on this page, as of the latest one.
Is Daniel Lochner buying or selling?
In the last 12 months Daniel Lochner reported 1 open-market buy worth $130k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $130k of TECX on Feb 10, 2026. Grants, option exercises and tax withholding are not counted.
How did Daniel Lochner's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Daniel Lochner has 0.
Where does Daniel Lochner file Form 4?
Daniel Lochner has filed Form 4 at TECX (Tectonic Therapeutic, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.